Suspended

SCOREExercise in Pediatric Autologous Stem Cell Transplant Patients: A Randomized Controlled Trial Protocol

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

EXERCISE (EX)

+ Standard Care

Other
Who is being recruted

Behavior

+ Motor Activity

+ Neoplasms

From 5 to 18 Years
See all eligibility criteria
How is the trial designed

Interventional
Study Start: June 2012
See protocol details

Summary

Principal SponsorUniversity of Calgary
Last updated: October 26, 2016
Sourced from a government-validated database.Claim as a partner

Study start date: June 1, 2012

Actual date on which the first participant was enrolled.

Hematopoietic stem cell transplantation is an intensive therapy used to improve survivorship and cure various oncologic diseases. However, this therapy is associated with high mortality rates and numerous negative side-effects. The recovery of the immune system is a special concern and plays a key role in the success of this treatment. In healthy populations it is known that exercise plays an important role in immune system regulation, but little is known about the role of exercise in the hematological and immunological recovery of children undergoing hematopoietic stem cell transplant. The Primary objective of this Randomized Controlled Trial is: study the effect of an exercise program on immune cell recovery in patients undergoing autologous stem cell transplantation. The Secondary objective is to determine if an exercise intervention might diminish the deterioration of quality of life, physical fitness, and the acquisition of a sedentary lifestyle. Methods Twenty-four participants treated for a malignancy with autologous stem cell transplant (5 to 18 years) in the Alberta Children's Hospital will be randomly assigned to an exercise or control group. The exercise group will participate in a two-phase exercise intervention (in and outpatient) from hospitalization until 10 weeks after discharge. The exercise program includes strength, flexibility and aerobic exercise. During the inpatient phase this program will be performed 5 times/week and will be supervised. The outpatient phase will combine a supervised session with two home-based exercise sessions with the use of the Wii device. The control group will follow the standard protocol without any specific exercise program. A range of outcomes, including quantitative and functional recovery of immune system, cytokine levels in serum, NK cells and their subset recovery and function, and gene expression of activating and inhibitory NK cell receptors, body composition, nutrition, quality of life, fatigue, health-related fitness assessment and physical activity levels will be examined, providing the most comprehensive assessment to date. Discussion We expect to find an improvement in the immunological recovery, quality of life, decreased acquisition of sedentary behavior and less fitness deconditioning.

NCT01666015
Principal SponsorUniversity of Calgary
Last updated: October 26, 2016
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

24 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.



Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 5 to 18 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

BehaviorMotor ActivityNeoplasms

Criteria

Inclusion Criteria: autologous SCT at Alberta Children's Hospital (ACH) for malignancy age 5 to 18 years of age will be receiving myeloablative conditioning regimen no evidence of cardiac or pulmonary failure associated with treatment (SF≥28%, EF ≥ 50%) no functional nor cognitive limitation that would prohibit performance of the home-based training approval by treating oncologist for participants a parent or legal guardian must sign the consent form and children should express verbal assent to participate. Exclusion Criteria: -

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

2 intervention groups are designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Experimental
This group will perform two phases of an EX program.

Group II

Active Comparator
This group will follow the standard care without any EX prescription.

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 2 locations

University of Calgary

Calgary, CanadaOpen University of Calgary in Google Maps

Alberta Children's Hospital

Calgary, Canada
Suspended2 Study Centers